What happened
arXiv:2609.13470v1 Announce Type: new Abstract: Although large language models (LLMs) have demonstrated remarkable capabilities, their reliance on cloud-scale infrastructure poses fundamental challenges for deployment in agentic pipelines, including latency, privacy, connectivity, and substantial computational cost. Small language models (SLMs) offer a compelling alternative: recent studies suggest that many repetitive and narrowly scoped subtasks in agentic workloads may be better served by specialized SLMs than by monolithic LLMs. However, the limited capacity and context windows of SLMs can constrain long-horizon reasoning and interaction-heavy orchestration strategies such as iterative verification and debate. This motivates a complementary, non-interactive paradigm in which heterogeneous SLMs independently generate candidate solutions and a router orchestrates their cached samples without further model interaction. To further understand the mechanisms of such orchestration, we introduce OrchSLM, a routing framework that unifies existing non-interactive orchestration methods and exposes their underlying design choices as controllable parameters. Using OrchSLM as a systematic probe, we reveal how orchestration behavior emerges from diverse knobs, including the task structure, model-pool composition, and multi-agent consensus. Update (2026-09-18): Safety Beyond the Interface: Detecting Harm via Latent States in Large Language Models. arXiv:2609.19472v1 Announce Type: new Abstract: Autonomous systems increasingly rely on Large Language Models (LLMs) yet the safety infrastructure surrounding these models introduces latency and compute overhead. This limits utility in resource-constrained, time-critical deployments. Existing external guardrail models remain blind to the model's internal workings, creating a fundamental assurance gap. We ask: does the model already know when the content is harmful? We extract activations from LLaMA-3.1-8B and train lightweight MLP classifier probes (12.6M parameters) to detect harmful prompts. Evaluated on WildJailbreak, Beavertails, and AEGIS 2.0, our probes achieve F1 scores of 99%, 83%, and 84%, respectively competitive with 1000x larger guard models while cutting latency and compute costs. Update (2026-09-25): STAT+: Lilly wins approval for once-weekly insulin shot. The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an alternative to daily long-acting insulin injections.